Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NorthView Acquisition | NVAC | 22. nov 2024 | 11.71 | 0.00 |
Northwest Bancshares | NWBI | 22. nov 2024 | 14.93 | +2.05 |
Northwest Natural Holdings | NWN | 22. nov 2024 | 43.78 | +1.32 |
Northwest Pipe | NWPX | 22. nov 2024 | 56.29 | +1.96 |
NorthWestern Energy | NWE | 22. nov 2024 | 56.75 | +0.42 |
Norwegian Cruise Line | NCLH | 22. nov 2024 | 26.86 | +0.37 |
Norwood Financial | NWFL | 22. nov 2024 | 30.51 | +2.28 |
Notable Labs | NTBL | 22. nov 2024 | 0.34 | 0.00 |
Nouveau Monde Graphite | NMG | 22. nov 2024 | 1.26 | +0.80 |
NOV | NOV | 22. nov 2024 | 16.61 | +1.28 |
Nova | NVMI | 22. nov 2024 | 179.76 | +0.02 |
Nova Lifestyle | NVFY | 22. nov 2024 | 0.61 | +2.40 |
Nova Minerals | NVA | 22. nov 2024 | 8.16 | +1.49 |
Nova Vision Acquisition | NOVV | 22. nov 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | 22. nov 2024 | 0.68 | -5.39 |
Novagold Resources | NG | 22. nov 2024 | 3.65 | +1.39 |
Novanta | NOVT | 22. nov 2024 | 169.79 | +3.08 |
Novartis ADR | NVS | 22. nov 2024 | 104.28 | +0.41 |
Novavax | NVAX | 22. nov 2024 | 8.47 | +5.35 |
Novo Integrated Sciences | NVOS | 22. nov 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | 22. nov 2024 | 105.06 | +2.37 |
NovoCure | NVCR | 22. nov 2024 | 17.73 | +3.74 |
Novonix ADR | NVX | 22. nov 2024 | 1.93 | +0.52 |
NRG Energy | NRG | 22. nov 2024 | 95.48 | -1.46 |
NRx Pharmaceuticals | NRXP | 22. nov 2024 | 1.26 | +2.44 |
NSTS Bancorp | NSTS | 22. nov 2024 | 11.24 | +0.45 |
Nu Holdings | NU | 22. nov 2024 | 13.91 | +3.81 |
Nu Skin Enterprises | NUS | 22. nov 2024 | 7.22 | -1.10 |
Nuburu | BURU | 22. nov 2024 | 0.47 | +2.50 |
NuCana ADR | NCNA | 22. nov 2024 | 1.23 | -3.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.